Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study

Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients.

The results showed the drug, Bavencio, in combination with, or as a follow-on treatment to, platinum-based chemotherapy could not achieve the primary goal of progression-fee survival in patients.

Last year, Bavencio, or avelumab, failed to prolong lives in a separate trial to evaluate the immunotherapy in gastric cancer patients.

Earlier this year, the drug did not show improvement in survival in lung cancer patients who had previously undergone unsuccessful chemotherapy.

The setbacks come at a time when the drug is competing against other immunotherapy cancer drugs such as Merck & Co’s Keytruda, Bristol-Myers Squibb’s Opdivo.

Every year, more than 295,000 women are diagnosed with ovarian cancer worldwide and the disease is generally advanced when it is diagnosed, as it often has few to no symptoms at the early stages.

Merck KGaA shares closed down 0.26 percent on the Frankfurt Stock Exchange at 93.36 euro, while those of Pfizer rose about 1 percent to $42.34.

(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Arun Koyyur)

  • Related Posts

    • Pharma
    • March 27, 2024
    • 105 views
    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

    • Pharma
    • March 27, 2024
    • 70 views
    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down